nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—cardial valve—dilated cardiomyopathy	0.431	0.538	CbGeAlD
Sulfisoxazole—EDNRA—cardiac ventricle—dilated cardiomyopathy	0.11	0.137	CbGeAlD
Sulfisoxazole—EDNRA—myocardium—dilated cardiomyopathy	0.103	0.129	CbGeAlD
Sulfisoxazole—EDNRA—heart—dilated cardiomyopathy	0.072	0.0898	CbGeAlD
Sulfisoxazole—EDNRA—cardiac atrium—dilated cardiomyopathy	0.0616	0.0768	CbGeAlD
Sulfisoxazole—CYP2C9—heart—dilated cardiomyopathy	0.0238	0.0297	CbGeAlD
Sulfisoxazole—EDNRA—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.0161	0.081	CbGpPWpGaD
Sulfisoxazole—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—dilated cardiomyopathy	0.013	0.0655	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00935	0.0471	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00869	0.0438	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0082	0.0413	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00737	0.0371	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00719	0.0363	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.0067	0.0338	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—RAC1—dilated cardiomyopathy	0.00602	0.0304	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00578	0.0291	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.0044	0.0222	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.0044	0.0222	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00409	0.0206	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—RAF1—dilated cardiomyopathy	0.00399	0.0201	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00344	0.0174	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00343	0.0173	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00338	0.0171	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.0032	0.0161	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0031	0.0156	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00306	0.0154	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00295	0.0149	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00295	0.0149	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00274	0.0138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00266	0.0134	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00265	0.0133	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00251	0.0127	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00241	0.0122	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00238	0.012	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00227	0.0114	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00225	0.0113	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00225	0.0113	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00216	0.0109	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00215	0.0108	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00209	0.0105	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00202	0.0102	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00173	0.00871	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0017	0.00857	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00164	0.00826	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0016	0.00805	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.0015	0.00754	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00127	0.0064	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00127	0.0064	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00122	0.00613	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00118	0.00595	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00115	0.00581	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00115	0.00581	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00114	0.00576	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00107	0.0054	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00105	0.0053	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00104	0.00523	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00103	0.00517	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000988	0.00498	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000976	0.00492	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000926	0.00467	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000886	0.00447	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000841	0.00424	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000767	0.00387	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000719	0.00362	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000687	0.00346	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000681	0.00343	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000681	0.00343	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000653	0.00329	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000633	0.00319	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000624	0.00315	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000613	0.00309	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000524	0.00264	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000497	0.0025	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000468	0.00236	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.00044	0.00222	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000433	0.00218	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000427	0.00215	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000398	0.00201	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000386	0.00194	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGT—dilated cardiomyopathy	0.000368	0.00186	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000297	0.0015	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000256	0.00129	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000243	0.00122	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000236	0.00119	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000213	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000175	0.000884	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	0.000108	0.000545	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	0.000105	0.000531	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	9.48e-05	0.000478	CbGpPWpGaD
